Apyx Medical Corporation (APYX)
NASDAQ: APYXHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
APYX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $101.10M
- EPS (TTM)
- -$0.19
- Dividend yield
- None
- 52-week range
- 2.25 – 5.08
- Day range
- 2.35 – 2.46
- Volume / Avg
- 100.12K / 146.81K
- Beta
- —
- Shares outstanding
- 42.12M
52-week range
APYX stock today
Apyx Medical (APYX) closed at $2.40 on Nov 20, up 0.42% (+$0.01), versus the S&P 500's 3.70% decline. At this level, APYX sits near the bottom of its 52-week range of $2.25 to $5.08: 52.8% below the high, set on Jun 9, 2026 and 6.7% above the low. APYX is down 31.4% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 40.0%.
Apyx Medical has posted a net loss over the last twelve months (EPS of -$0.19), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Apyx Medical
Company profileApyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Charles D. Goodwin II
- Headquarters
- Clearwater, FL
- Employees
- 205
- Website
- apyxmedical.com
Financial highlights
Full financialsIn fiscal 2025, Apyx Medical generated $52.8 million in revenue, up 9.9% from fiscal 2024. Apyx Medical reported a net loss of $11.2 million, compared with a loss of $23.5 million a year earlier. Gross margin was 62.5% (up from 61.0%) and operating margin -12.2%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $52.84M | $48.10M | $52.35M | $44.51M | $48.52M |
| Growth | +9.86% | -8.11% | +17.61% | -8.26% | +75.08% |
| Net income | $-11.21M | $-23.46M | $-18.71M | $-23.18M | $-15.17M |
| EPS (diluted) | — | — | $-0.54 | $-0.67 | $-0.44 |
Analyst forecast
ForecastConsensus (6 analysts)
strong_buy
Avg. price target
$6.50+170.83%
- Strong buy 2
- Buy 4
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 5, 2026
- EPS actual vs est.
- $-0.04 vs $-0.07
- Surprise
- +42.86%
APYX news
All APYX newsApyx Medical peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| LUNGPulmonx Corporation | 2.57 | -6.20% | $111.93M | vs APYX |
| NYXHNyxoah SA | 0.805 | -7.01% | $81.98M | vs APYX |
| STIMNeuronetics Inc. | 1.25 | +0.81% | $120.60M | vs APYX |
| SKINSkinHealth Systems Inc. Class A | 11.77 | -3.13% | $76.68M | vs APYX |
| LUCDLucid Diagnostics Inc. | 0.3727 | -3.52% | $72.57M | vs APYX |
| PYPDPolyPid Ltd. | 6.12 | -6.56% | $129.29M | vs APYX |
| QTEXQTREX Quantum Ltd. | 1.00 | -10.71% | $70.63M | vs APYX |
| KRMDKORU Medical Systems Inc. | 3.19 | -7.27% | $138.37M | vs APYX |
Indexes, lists and sector
Apyx Medical stock FAQ
What is Apyx Medical's stock price today?
APYX last traded at $2.40 as of Nov 20, 4:00 PM EST, up 0.42% on the day. Prices are delayed at least 15 minutes.
Who is Apyx Medical's CEO?
Mr. Charles D. Goodwin II is the chief executive officer of Apyx Medical Corporation, which has about 205 employees.
What is the APYX 52-week high?
The 52-week high for APYX is $5.08 and the 52-week low is $2.25. The stock is currently 52.8% below its high.